Stereospecific Metabolism ofR- andS-Warfarin by Human Hepatic Cytosolic Reductases-Reference-Cited by-同舟云学术

Stereospecific Metabolism ofR- andS-Warfarin by Human Hepatic Cytosolic Reductases

Published:2017-06-23 Issue:9 Volume:45 Page:1000-1007
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Barnette Dustyn A.,Johnson Bryce P.,Pouncey Dakota L.,Nshimiyimana Robert,Desrochers Linda P.,Goodwin Thomas E.,Miller Grover P.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference37 articles.

1. Effect of Experimental Kidney Disease on the Functional Expression of Hepatic Reductases

2. Downregulation of hepatic carbonyl reductase type 1 in end-stage renal disease;Alshogran;Drug Metab Lett,2015

3. Pharmacology and Management of the Vitamin K Antagonists

4. Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man

5. Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver;Breyer-Pfaff;Drug Metab Dispos,2004

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Salvianolate Injection on the Pharmacodynamics and Pharmacokinetics of Warfarin in Rats In vivo;Current Analytical Chemistry;2024-06

2. Other Phase I metabolic transformations;An Integrated Guide to Human Drug Metabolism;2024

3. Rodenticides;Patty's Toxicology;2023-09-22

4. Cytochrome P450 and Other Drug-Metabolizing Enzymes As Therapeutic Targets;Drug Metabolism and Disposition;2023-04-11

5. Pharmacokinetic and Pharmacologic Characterization of the Dihydrotetrabenazine Isomers of Deutetrabenazine and Valbenazine;Clinical Pharmacology in Drug Development;2022-12-18